back to company universe
AI infrastructure

Nabla Bio

Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.

sources
1
Evidence entries preserved.
affiliations
1
Y Combinator
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Y Combinator

yc-company-directory #1681

Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.

source
generated read
High Signal interpretation

Nabla Bio is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
AIpatientspharmaceutical and biotech companiesmassively parallel experimentationantibody therapiesdisease targetantibodiesHarvard University
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to Nabla Bio

AI infrastructure · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

Transcriptic

match 87

Founded in 2012, Transcriptic has developed the first robotic cloud lab platform for on-demand life science research. It’s powered by the Transcriptic Common Lab Environment (TCLE) a scalable, digital infrastructure that integrates laboratory processes, instruments and IoT technologies into a single user interface. Researchers can carry out scalable, reproducible and rapid experimentation from anywhere in the world. Top ten pharmaceutical companies, as well as emerging biotech companies, are usi

shared extracted concept terms: pharmaceutical, biotech, companie; shared product terms: pharmaceutical, biotech, companie, experimentation; shared affiliation: Y Combinator

CellChorus

match 79

At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and

shared extracted concept terms: biotech, companie; shared product terms: parallel, therapie, antibodie, companie; shared product theme: health and clinical care, sales and marketing; shared affiliation: Y Combinator

Macromoltek

match 69

Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.

shared extracted concept terms: biotech, antibody; shared product terms: antibody, design, enable, target; shared affiliation: Y Combinator

Mineflow

match 46

Mineflow is an AI platform for mineral exploration. We generate predictions for mineral deposit shapes and locations, empowering mining companies from initial exploration to advanced feasibility studies. Geologists need to know precisely where their deposits are because drilling is expensive. In early trials with a lithium mining company, we found that Mineflow predicts the shape of hard rock lithium deposits more than an order of magnitude more accurately than our competitors. Ryan received a B

shared extracted concept terms: companie; shared product terms: location, companie, precisely, found; same category: AI infrastructure; shared affiliation: Y Combinator

Lifebit Biotech

match 44

LifeBit enables companies to do DNA analysis at scale.

shared extracted concept terms: companie, biotech; shared product terms: enable, companie, biotech

Aradon

match 39

Aradon makes biotech robot labs easy to install and operate for scientists. Removing the manual work bottleneck from biotech will enable new medical solutions and enhance healthcare globally.

shared extracted concept terms: biotech; shared product terms: biotech, scientist, enable; shared product theme: health and clinical care